Friday, October 20, 2023
OrthoPediatrics Corp, a company dedicated to advancing the field of pediatric orthopedics, recently introduced its latest medical innovation, the Pediatric Nailing Platform TIBIA system. This groundbreaking system has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is part of the Trauma & Deformity Correction suite of products. The PNP Tibia system has been developed to cater specifically to the unique needs of pediatric patients dealing with fractures and deformities in the lower extremities. This expansion broadens the company's portfolio, now comprising 52 distinct systems designed exclusively for pediatric patients.
The PNP Tibia System provides a range of rigid cannulated nails with diameters ranging from 7mm to 12mm. It is complemented by specialized instrumentation that supports a variety of surgical techniques. As is characteristic of all OrthoPediatrics products, this system has been meticulously crafted to align with the anatomical characteristics and growth patterns of children.
The system's versatility was demonstrated through two distinct surgical cases: one involving a trauma procedure for a tall teenager requiring a large nail (12mm X 420mm) and the other addressing a deformity correction procedure for a smaller 15-year-old patient, for which a 7mm X 285mm nail was used. These successful cases showcase the system's efficacy, highlighting the potential benefits it holds for numerous pediatric patients in the future.
Source: globenewswire.com
